About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: November 15, 2007
The FDA’s BTC Meeting
The FDA held an all day public meeting yesterday here in Washington to gain insight into the possibility of a Behind-the-Counter (BTC) designation for drugs. BTC would be non-prescription, but would require the intervention of a learned intermediary – i.e., … Continue reading
Posted in FDA Policy
Comments Off on The FDA’s BTC Meeting